next generation GABA A allosteric modulator (SAGE Therapeutics)

N/A

Report date: 2025/11/17 14:45:24
NME

Base Information

Drug Namenext generation GABA A allosteric modulator (SAGE Therapeutics)
Drug Alias Namenext generation GABA A allosteric modulator (SAGE Therapeutics)SAGE-NCE (SAGE Therapeutics)
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor modulatorsNeuroprotectants
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsStatus Epilepticus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSage Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStatus Epilepticus

Other Information

ATC CodeN/A
Related LinksN/A